Concepedia

Publication | Open Access

Resistance to the mTOR-inhibitor RAD001 elevates integrin α2- and β1-triggered motility, migration and invasion of prostate cancer cells

37

Citations

34

References

2012

Year

Abstract

Chronic RAD001 treatment caused resistance development characterised by distinct modification of the integrin-expression profile, driving prostate cancer cells towards high motility.

References

YearCitations

Page 1